IPIC - the obesity pill stock Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC - the obesity pill stock

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rich Benjamin who wrote ()	9/23/1996 5:49:00 AM
From: Cuong Huy Nguyen	of 113

I read the article in TIME also, and was impressed until I called up my sister who is a pharmacist. She tells me that Wyeth-Ayerst recently sent out letters warning about potential primary pulmonary hypertension side-effects. Other diet pills based on fen/phen are still outselling Redux ten-to-one. Patients she has seen coming to the pharmacy to get Redux don't seem to be losing weight very quickly (only a few pounds per month). Also Redux costs a lot more than current drugs. I asked her to keep me advised if things change, which is possible considering the hype that it's getting, and also since it just came out onto the market. I read an article from PRNewswire about the PPH problem that said Redux increased the risk of getting PPH by about 23 times. But in absolute terms, it doesn't seem that big a deal. The risk of PPH while using Redux is 23 to 46 cases per one million patients per year. PPH occurs in the general population at 1 to 2 per one million. Pretty small numbers in either case. I'm still undecided at this point whether to buy IPIC or not. I think I'll go with my sister's judgement for now.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next